Gregory H. Bailey - 28 Apr 2022 Form 4 Insider Report for Biohaven Pharmaceutical Holding Co Ltd.

Role
Director
Signature
/s/ George Clark, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
28 Apr 2022
Net transactions value
$0
Form type
4
Filing time
29 Apr 2022, 20:59:31 UTC
Previous filing
23 Jun 2021
Next filing
22 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Stock Option (Right to Buy) Award $0 +8,239 $0.000000 8,239 28 Apr 2022 Common Shares 8,239 $97.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2023 or (b) the date of the 2023 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date.

Remarks:

Exhibit List: Exhibit 24: Power of attorney